REFERENCES
1. Peters AL, Van Stein D, Vlaar AP.
Antibody-mediated transfusion-related acute lung injury; from discovery
to prevention. British journal of haematology. 2015;170(5):597-614.
2. Vlaar AP, Juffermans NP.
Transfusion-related acute lung injury: a clinical review. Lancet
(London, England). 2013;382(9896):984-94.
3. Roubinian N. TACO and TRALI:
biology, risk factors, and prevention strategies. Hematology American
Society of Hematology Education Program. 2018;2018(1):585-94.
4. Peters AL, van Hezel ME, Juffermans
NP, Vlaar AP. Pathogenesis of non-antibody mediated transfusion-related
acute lung injury from bench to bedside. Blood reviews.
2015;29(1):51-61.
5. Andreu G, Boudjedir K, Muller JY,
Pouchol E, Ozier Y, Fevre G, et al. Analysis of Transfusion-Related
Acute Lung Injury and Possible Transfusion-Related Acute Lung Injury
Reported to the French Hemovigilance Network From 2007 to 2013.
Transfusion medicine reviews. 2018;32(1):16-27.
6. Vlaar AP, Binnekade JM, Prins D,
van Stein D, Hofstra JJ, Schultz MJ, et al. Risk factors and outcome of
transfusion-related acute lung injury in the critically ill: a nested
case-control study. Critical care medicine. 2010;38(3):771-8.
7. Vlaar APJ, Toy P, Fung M, Looney
MR, Juffermans NP, Bux J, et al. An update of the transfusion-related
acute lung injury (TRALI) definition. Transfusion clinique et biologique
: journal de la Societe francaise de transfusion sanguine. 2019.
8. Toy P, Gajic O, Bacchetti P, Looney
MR, Gropper MA, Hubmayr R, et al. Transfusion-related acute lung injury:
incidence and risk factors. Blood. 2012;119(7):1757-67.
9. Semple JW, Rebetz J, Kapur R.
Transfusion-associated circulatory overload and transfusion-related
acute lung injury. Blood. 2019;133(17):1840-53.
10. Roubinian NH, Looney MR, Kor DJ,
Lowell CA, Gajic O, Hubmayr RD, et al. Cytokines and clinical predictors
in distinguishing pulmonary transfusion reactions. Transfusion.
2015;55(8):1838-46.
11. Semple JW, McVey MJ, Kim M,
Rebetz J, Kuebler WM, Kapur R. Targeting Transfusion-Related Acute Lung
Injury: The Journey From Basic Science to Novel Therapies. Critical care
medicine. 2018;46(5):e452-e8.
12. Ducharme-Crevier L, Lacroix J.
Interleukin-1 Receptor Antagonist and Interleukin-1beta: Risk Marker or
Risk Factor for Pediatric Acute Respiratory Distress Syndrome? Pediatric
critical care medicine : a journal of the Society of Critical Care
Medicine and the World Federation of Pediatric Intensive and Critical
Care Societies. 2018;19(10):993-5.
13. Pepys MB, Hirschfield GM.
C-reactive protein: a critical update. The Journal of clinical
investigation. 2003;111(12):1805-12.
14. Kapur R, Kim M,
Shanmugabhavananthan S, Liu J, Li Y, Semple JW. C-reactive protein
enhances murine antibody-mediated transfusion-related acute lung injury.
Blood. 2015;126(25):2747-51.
15. Kapur R, Kim M, Rondina MT,
Porcelijn L, Semple JW. Elevation of C-reactive protein levels in
patients with transfusion-related acute lung injury. Oncotarget.
2016;7(47):78048-54.
16. Pechous RDJFic, microbiology i.
With friends like these: the complex role of neutrophils in the
progression of severe pneumonia. 2017;7:160.
17. McNamara R, Deane AM, Anstey J,
Bellomo R. Understanding the rationale for parenteral ascorbate (vitamin
C) during an acute inflammatory reaction: a biochemical perspective.
Critical care and resuscitation : journal of the Australasian Academy of
Critical Care Medicine. 2018;20(3):174-9.
18. Carr AC, Rosengrave PC, Bayer S,
Chambers S, Mehrtens J, Shaw GM. Hypovitaminosis C and vitamin C
deficiency in critically ill patients despite recommended enteral and
parenteral intakes. Critical care (London, England). 2017;21(1):300.
19. Margaritelis NV, Paschalis V,
Theodorou AA, Vassiliou V, Kyparos A, Nikolaidis MG. Rapid decreases of
key antioxidant molecules in critically ill patients: A personalized
approach. Clinical nutrition (Edinburgh, Scotland). 2019.
20. Carr AC, Maggini SJN. Vitamin C
and immune function. 2017;9(11):1211.
21. Hartmann SE, Waltz X, Kissel CK,
Szabo L, Walker BL, Leigh R, et al. Cerebrovascular and ventilatory
responses to acute isocapnic hypoxia in healthy aging and lung disease:
effect of vitamin C. Journal of applied physiology (Bethesda, Md :
1985). 2015;119(4):363-73.
22. Gaweł S, Wardas M, Niedworok E,
Wardas P. [Malondialdehyde (MDA) as a lipid peroxidation marker].
Wiadomosci lekarskie (Warsaw, Poland : 1960). 2004;57(9-10):453-5.
23. Reynolds PS, Fisher BJ, McCarter
J, Sweeney C, Martin EJ, Middleton P, et al. Interventional vitamin C: A
strategy for attenuation of coagulopathy and inflammation in a swine
multiple injuries model. The journal of trauma and acute care surgery.
2018;85(1S Suppl 2):S57-s67.
24. Washko P, Rotrosen D, Levine
MJJoBC. Ascorbic acid transport and accumulation in human neutrophils.
1989;264(32):18996-9002.
25. Evans RM, Currie L, Campbell
AJBJoN. The distribution of ascorbic acid between various cellular
components of blood, in normal individuals, and its relation to the
plasma concentration. 1982;47(3):473-82.
26. Corpe CP, Lee J-H, Kwon O, Eck P,
Narayanan J, Kirk KL, et al. 6-Bromo-6-deoxy-L-ascorbic acid: an
ascorbate analog specific for Na+-dependent vitamin C transporter but
not glucose transporter pathways. 2005;280(7):5211-20.
27. Vissers M, Hampton MJBST. The
role of oxidants and vitamin C on neutrophil apoptosis and clearance.
2004;32(3):499-501.
28. Wang Y, Lin H, Lin BW, Lin JD.
Effects of different ascorbic acid doses on the mortality of critically
ill patients: a meta-analysis. Annals of intensive care. 2019;9(1):58.
29. Rozemeijer S, Spoelstra-de Man
AME, Coenen S, Smit B, Elbers PWG, de Grooth H-J, et al. Estimating
Vitamin C Status in Critically Ill Patients with a Novel Point-of-Care
Oxidation-Reduction Potential Measurement. Nutrients. 2019;11(5):1031.
30. Fowler AA, 3rd, Truwit JD, Hite
RD, Morris PE, DeWilde C, Priday A, et al. Effect of Vitamin C Infusion
on Organ Failure and Biomarkers of Inflammation and Vascular Injury in
Patients With Sepsis and Severe Acute Respiratory Failure: The
CITRIS-ALI Randomized Clinical Trial. Jama. 2019;322(13):1261-70.
31. Toy P, Popovsky MA, Abraham E,
Ambruso DR, Holness LG, Kopko PM, et al. Transfusion-related acute lung
injury: definition and review. Critical care medicine. 2005;33(4):721-6.
32. Kleinman S, Caulfield T, Chan P,
Davenport R, McFarland J, McPhedran S, et al. Toward an understanding of
transfusion-related acute lung injury: statement of a consensus panel.
Transfusion. 2004;44(12):1774-89.
33. de Grooth HJ, Manubulu-Choo WP,
Zandvliet AS, Spoelstra-de Man AME, Girbes AR, Swart EL, et al. Vitamin
C Pharmacokinetics in Critically Ill Patients: A Randomized Trial of
Four IV Regimens. Chest. 2018;153(6):1368-77.
34. Fowler AA, III, Fisher BJ,
Kashiouris MG. Vitamin C for Sepsis and Acute Respiratory
Failure—Reply. Jama. 2020;323(8):792-3.
35. Zhang J, Rao X, Li Y, Zhu Y, Liu
F, Guo G, et al. Pilot trial of high-dose vitamin C in critically ill
COVID-19 patients. Annals of intensive care. 2021;11(1):5.
36. Klimant E, Wright H, Rubin D,
Seely D, Markman M. Intravenous vitamin C in the supportive care of
cancer patients: a review and rational approach. Current oncology
(Toronto, Ont). 2018;25(2):139-48.
37. Fowler AA, 3rd, Syed AA, Knowlson
S, Sculthorpe R, Farthing D, DeWilde C, et al. Phase I safety trial of
intravenous ascorbic acid in patients with severe sepsis. J Transl Med.
2014;12:32-.
38. Marik PE, Khangoora V, Rivera R,
Hooper MH, Catravas JJC. Hydrocortisone, vitamin C, and thiamine for the
treatment of severe sepsis and septic shock: a retrospective
before-after study. 2017;151(6):1229-38.
39. Al Sulaiman K, Al Juhani O, Salah
KB, Badreldin HA, Al Harthi A, Alenazi M, et al. Ascorbic Acid as an
Adjunctive Therapy in Critically Ill Patients with COVID-19: A
Multicenter Propensity Score Matched Study. 2021.
40. Li W, Maeda N, Beck MAJTJon.
Vitamin C deficiency increases the lung pathology of influenza
Virus–Infected gulo−/− mice. 2006;136(10):2611-6.
41. Fisher BJ, Kraskauskas D, Martin
EJ, Farkas D, Wegelin JA, Brophy D, et al. Mechanisms of attenuation of
abdominal sepsis induced acute lung injury by ascorbic acid. 2012.
42. Kashiouris MG, L’Heureux M, Cable
CA, Fisher BJ, Leichtle SWJN. The emerging role of vitamin C as a
treatment for sepsis. 2020;12(2):292.
43. Truwit JD, Hite RD, Morris PE,
DeWilde C, Priday A, Fisher B, et al. Effect of vitamin C infusion on
organ failure and biomarkers of inflammation and vascular injury in
patients with sepsis and severe acute respiratory failure: the
CITRIS-ALI randomized clinical trial. 2019;322(13):1261-70.
44. Marik PE, Payen D. CITRIS-ALI:
how statistics were used to obfuscate the true findings. 2019.
45. Hemilä H, Chalker EJJoic. Vitamin
C may reduce the duration of mechanical ventilation in critically ill
patients: a meta-regression analysis. 2020;8(1):1-9.
46. JamaliMoghadamSiahkali S,
Zarezade B, Koolaji S, SeyedAlinaghi S, Zendehdel A, Tabarestani M, et
al. Safety and effectiveness of high-dose vitamin C in patients with
COVID-19: a randomized open-label clinical trial. 2021;26(1):1-9.
47. Wang Y, Lin H, Lin B-w, Lin
J-dJAoic. Effects of different ascorbic acid doses on the mortality of
critically ill patients: a meta-analysis. 2019;9(1):1-13.
48. Carr AC, Shaw GM, Natarajan RJCC.
Ascorbate-dependent vasopressor synthesis: a rationale for vitamin C
administration in severe sepsis and septic shock? 2015;19(1):1-8.
49. Zabet MH, Mohammadi M, Ramezani
M, Khalili HJJoripp. Effect of high-dose ascorbic acid on vasopressor’s
requirement in septic shock. 2016;5(2):94.
50. Li M, Ching TH, Hipple C, Lopez
R, Sahibzada A, Rahman H. Use of Intravenous Vitamin C in Critically Ill
Patients With COVID-19 Infection. 2021;0(0):08971900211015052.
51. Syed AA, Knowlson S, Sculthorpe
R, Farthing D, DeWilde C, Farthing CA, et al. Phase I safety trial of
intravenous ascorbic acid in patients with severe sepsis.
2014;12(1):1-10.
52. Ferrón-Celma I, Mansilla A,
Hassan L, Garcia-Navarro A, Comino A-M, Bueno P, et al. Effect of
vitamin C administration on neutrophil apoptosis in septic patients
after abdominal surgery. 2009;153(2):224-30.
53. de Grooth H-J, Manubulu-Choo W-P,
Zandvliet AS, Spoelstra-de Man AM, Girbes AR, Swart EL, et al. Vitamin C
pharmacokinetics in critically ill patients: a randomized trial of four
IV regimens. 2018;153(6):1368-77.
54. McNamara R, Deane AM, Anstey J,
Bellomo RJCC, Resuscitation. Understanding the rationale for parenteral
ascorbate (vitamin C) during an acute inflammatory reaction: a
biochemical perspective. 2018;20(3):174-9.